815 related articles for article (PubMed ID: 8529468)
1. DNA ploidy and proliferation heterogeneity in human prostate cancers.
Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
[TBL] [Abstract][Full Text] [Related]
2. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
3. The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancer.
Häggarth L; Auer G; Busch C; Norberg M; Häggman M; Egevad L
Scand J Urol Nephrol; 2005; 39(5):387-92. PubMed ID: 16257840
[TBL] [Abstract][Full Text] [Related]
4. Factors that influence the measurement of prostate cancer DNA ploidy and proliferation in paraffin embedded tissue evaluated by flow cytometry.
So MJ; Cheville JC; Katzmann JA; Riehle DL; Lohse CM; Pankratz VS; Sebo TJ
Mod Pathol; 2001 Sep; 14(9):906-12. PubMed ID: 11557788
[TBL] [Abstract][Full Text] [Related]
5. Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer.
Frankfurt OS; Chin JL; Englander LS; Greco WR; Pontes JE; Rustum YM
Cancer Res; 1985 Mar; 45(3):1418-23. PubMed ID: 3971384
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
7. DNA ploidy by image analysis of individual foci of prostate cancer: a preliminary report.
Greene DR; Taylor SR; Wheeler TM; Scardino PT
Cancer Res; 1991 Aug; 51(15):4084-9. PubMed ID: 1855223
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric evaluation of early invasive cervical cancer.
Connor JP; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR
Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788
[TBL] [Abstract][Full Text] [Related]
9. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
Meyer JS; Gersell DJ; Yim S
Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy.
Abaza R; Diaz LK; Laskin WB; Pins MR
J Urol; 2006 Dec; 176(6 Pt 1):2701-5. PubMed ID: 17085199
[TBL] [Abstract][Full Text] [Related]
11. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
12. Ploidy results in prostatic carcinoma vary with sampling method and with cytometric technique.
Hardt NS; Hendricks JB; Sapi Z; Tykochinsky G; Wilkinson EJ; Epstein HB; Wajsman Z
Mod Pathol; 1994 Jan; 7(1):44-8. PubMed ID: 8159651
[TBL] [Abstract][Full Text] [Related]
13. DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma.
Lee AK; Wiley B; Loda M; Bosari S; Dugan JM; Hamilton W; Heatley GJ; Cook L; Silverman ML
Mod Pathol; 1992 Jan; 5(1):61-7. PubMed ID: 1347424
[TBL] [Abstract][Full Text] [Related]
14. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
Masood S; Bui MM; Lu L
Ann Clin Lab Sci; 1998; 28(6):315-23. PubMed ID: 9846198
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
[TBL] [Abstract][Full Text] [Related]
16. Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis.
Bratt O; Anderson H; Bak-Jensen E; Baldetorp B; Lundgren R
Urology; 1996 Feb; 47(2):218-24. PubMed ID: 8607238
[TBL] [Abstract][Full Text] [Related]
17. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
[TBL] [Abstract][Full Text] [Related]
18. DNA image cytometry of prostatic carcinoma: a comparison of needle core biopsy and subsequent prostatectomy specimens.
Leung CS; Zbieranowski I; Demers J; Murray D
Mod Pathol; 1994 Feb; 7(2):195-9. PubMed ID: 8008743
[TBL] [Abstract][Full Text] [Related]
19. Near tetraploid prostate carcinoma. Methodologic and prognostic aspects.
Forsslund G; Nilsson B; Zetterberg A
Cancer; 1996 Oct; 78(8):1748-55. PubMed ID: 8859188
[TBL] [Abstract][Full Text] [Related]
20. [The clinical usefulness of flow cytometric DNA analysis in prostatic cancer].
Ishikawa A
Hinyokika Kiyo; 1992 Jun; 38(6):665-70. PubMed ID: 1632320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
